MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases
Crossref DOI link: https://doi.org/10.1038/bjc.2014.263
Published Online: 2014-05-22
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nagy, E
Gajjar, K B
Patel, I I
Taylor, S
Martin-Hirsch, P L
Stringfellow, H F
Martin, F L
Phillips, D H
License valid from 2014-05-22
Article History
Received: 21 February 2014
Accepted: 23 April 2014
First Online: 22 May 2014